Allan-Blitz L, Mayer K
Curr HIV/AIDS Rep. 2024; 22(1):1.
PMID: 39476167
DOI: 10.1007/s11904-024-00709-w.
Mortimer T, Grad Y
Clin Infect Dis. 2023; 77(5):788-791.
PMID: 37138444
PMC: 10495131.
DOI: 10.1093/cid/ciad279.
Mortimer T, Grad Y
medRxiv. 2023; .
PMID: 36993406
PMC: 10055447.
DOI: 10.1101/2023.03.14.23287223.
Kirkcaldy R, Weinstock H, Moore P, Philip S, Wiesenfeld H, Papp J
Clin Infect Dis. 2014; 59(8):1083-91.
PMID: 25031289
PMC: 4271098.
DOI: 10.1093/cid/ciu521.
Yoshikawa T, Miyamoto S, Chow A, Guze L
Antimicrob Agents Chemother. 1974; 6(3):327-9.
PMID: 15830482
PMC: 444646.
DOI: 10.1128/AAC.6.3.327.
Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.
Fekete T
Clin Microbiol Rev. 1993; 6(1):22-33.
PMID: 8457978
PMC: 358264.
DOI: 10.1128/CMR.6.1.22.
Treatment of uncomplicated gonorrhea with rosoxacin.
Handsfield H, Judson F, Holmes K
Antimicrob Agents Chemother. 1981; 20(5):625-9.
PMID: 6798924
PMC: 181763.
DOI: 10.1128/AAC.20.5.625.
Pharmacological and in vitro evaluation of cyclacillin: assessment as potential single-dose therapy for treatment of Neisseria gonorrhoeae infection.
Wagner K, Blair A, COUNTS G, Holmes K
Antimicrob Agents Chemother. 1980; 17(1):89-91.
PMID: 6766294
PMC: 283732.
DOI: 10.1128/AAC.17.1.89.
Rosoxacin in the therapy of uncomplicated gonorrhea.
Romanowski B, Austin T, PATTISON F, Lawee D, Portnoy D, Givan K
Antimicrob Agents Chemother. 1984; 25(4):455-7.
PMID: 6428307
PMC: 185551.
DOI: 10.1128/AAC.25.4.455.
Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.
Handsfield H, Murphy V, Holmes K
Antimicrob Agents Chemother. 1981; 20(6):839-40.
PMID: 6275788
PMC: 181809.
DOI: 10.1128/AAC.20.6.839.
Therapeutic trial and pharmacokinetics of sulbactam for uncomplicated gonorrhea in men.
Caine V, Foulds G, Handsfield H
Antimicrob Agents Chemother. 1984; 26(5):683-5.
PMID: 6097173
PMC: 179994.
DOI: 10.1128/AAC.26.5.683.
Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea.
Karney W, Turck M, Holmes K
Antimicrob Agents Chemother. 1974; 5(2):114-8.
PMID: 4599858
PMC: 428931.
DOI: 10.1128/AAC.5.2.114.
Antibiotic sensitivities of Neisseria gonorrhoeae in the Toronto area.
Givan K, Keyl A
Can Med Assoc J. 1974; 111(1):44-6.
PMID: 4276273
PMC: 1947557.
Gonococcal infections. Laboratory, clinical and epidemiological aspects.
Anthony B, Keys T, Louie J, Yoshimori R
West J Med. 1974; 120(6):456-62.
PMID: 4210923
PMC: 1130177.
Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin.
Verdon M, Judson F, Ehret J, Root C, Hook 3rd E, McCormack W
Antimicrob Agents Chemother. 1988; 32(5):773-4.
PMID: 3395105
PMC: 172272.
DOI: 10.1128/AAC.32.5.773.
Norfloxacin in the therapy of uncomplicated gonorrhea.
Romanowski B, Wood H, Draker J, Tsianco M
Antimicrob Agents Chemother. 1986; 30(3):514-5.
PMID: 3096197
PMC: 180593.
DOI: 10.1128/AAC.30.3.514.
Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
Roddy R, Handsfield H, Hook 3rd E
Antimicrob Agents Chemother. 1986; 30(2):267-9.
PMID: 3094439
PMC: 180532.
DOI: 10.1128/AAC.30.2.267.
Comparative study of cefoperazone and spectinomycin for treatment of uncomplicated gonorrhea in men.
Hook 3rd E, Judson F, Verdon M, Ehret J, Handsfield H
Antimicrob Agents Chemother. 1986; 30(4):619-21.
PMID: 2947537
PMC: 176494.
DOI: 10.1128/AAC.30.4.619.
Comparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.
Yoshikawa T, Miyamoto S, Guze L
Antimicrob Agents Chemother. 1975; 8(5):515-7.
PMID: 813569
PMC: 429409.
DOI: 10.1128/AAC.8.5.515.
Male urethritis in King County, Washington, 1974-75: II. Diagnosis and treatment.
Hinds M, Gale J
Am J Public Health. 1978; 68(1):26-30.
PMID: 623359
PMC: 1653847.
DOI: 10.2105/ajph.68.1.26.
